Interleukin-1β rs1143627 polymorphism with susceptibility to periodontal disease
Metrics: PDF 922 views | HTML 1251 views | ?
Wei Huang1,*, Bing-Yang He2,*, Jun Shao3,*, Xiao-Wei Jia3 and Ya-Di Yuan3
1Department of Stomatology, Zhuhai People’s Hospital, Zhuhai Hospital Affiliated With Jinan University, Zhuhai 519099, Guangdong Province, China
2Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China
3Department of Stomatology, Guangzhou Hospital of Integrated Traditional and West Medicine, Guangzhou 510800, Guangdong Province, China
*Wei Huang, Bing-Yang He and Jun Shao are the co-first authors
Wei Huang, email: email@example.com
Keywords: interleukin-1, periodontitis, periodontal disease, meta-analysis, polymorphism
Received: December 12, 2016 Accepted: January 17, 2017 Published: February 22, 2017
Association between interleukin-1 beta (IL-1β) rs1143627 polymorphism and periodontal disease susceptibility was inconsistent; hence we performed this meta-analysis to explore the precise correlation between them. The degree of association was appraised through calculating pooled odds ratio (OR) and its 95% confidence interval (CI). The databases known as PubMed, Embase, and Chinese National Knowledge Infrastructure were searched up to October 26, 2016. A total of 8 eligible case-control studies were finally included, which involved 229 aggressive periodontitis patients, 382 chronic periodontitis patients, and 555 healthy controls. All the five genetic models revealed a non-significant association between IL-1β rs1143627 polymorphism and periodontal disease susceptibility (TT vs. CC: OR = 1.22, 95% CI = 0.80-1.87; CT+TT vs. CC: OR = 0.66, 95% CI = 0.44-1.01; TT vs. CT + CC: OR = 1.19, 95% CI = 0.81-1.74; T vs. C: OR = 0.92, 95% CI = 0.81-1.12; CT vs. CC: OR = 0.92, 95% CI = 0.69-1.23). Sensitivity analyses indicated that the results were robust and the subgroup analyses reached similar conclusions. IL-1β rs1143627 polymorphism is not related to periodontal disease susceptibility in the overall population based on the current evidence, but further studies are required in more large scale sample size with risk factor adjusted.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.